Clinical Trials Logo

Essential Tremor clinical trials

View clinical trials related to Essential Tremor.

Filter by:

NCT ID: NCT01932463 Completed - Essential Tremor Clinical Trials

ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) for Treatment of Tremor

Start date: May 2011
Phase: N/A
Study type: Interventional

A feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Tremor

NCT ID: NCT01909531 Enrolling by invitation - Parkinson's Disease Clinical Trials

Deep Brain Stimulation (DBS) Data Base Study

Start date: April 2013
Phase:
Study type: Observational

The primary goal of this study is to evaluate and compare outcomes, trends, and effectiveness of both awake and asleep Deep Brain Stimulation (DBS) surgical treatments, target selection, targeting accuracy and outcomes in patients with Parkinson's disease and Essential tremor.

NCT ID: NCT01864525 Completed - Voice Tremor Clinical Trials

Effects of Octanoic Acid for Treatment of Essential Voice Tremor

Start date: July 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Essential voice tremor is a neurological condition that produces a regular, shaking quality in the voice. One form of drug treatment that produces some improvement in tremor of the hands is octanoic acid, which is a food additive that is similar to alcohol. Research suggests that octanoic acid may reduce tremor in the hands/arms with few side effects and no intoxication effects. This study will determine whether octanoic acid may be useful for reducing tremor when it affects the voice. Researchers are hypothesizing that octanoic acid will reduce the effects of tremor on the voice.

NCT ID: NCT01827904 Completed - Essential Tremor Clinical Trials

ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors

Start date: May 2013
Phase: N/A
Study type: Interventional

The objective of this prospective, randomized, double-blind (to subjects, local site's blinded assessor and Tremor Core Lab assessors), crossover, multi-site, two-arm study (ExAblate treated arm Vs ExAblate Sham treated control arm) is to test the efficacy of treatment using the ExAblate Transcranial System and to further demonstrate safety in medication-refractory tremor in subjects with essential tremor (ET).

NCT ID: NCT01820390 Withdrawn - Parkinson's Disease Clinical Trials

Optimizing DBS Electrode Placement and Programming

Start date: March 2013
Phase: N/A
Study type: Observational

Deep brain stimulation (DBS) has become the primary surgical therapy for the treatment of motor symptoms associated with Parkinson's disease (PD), and for essential tremor (ET). Although an effective and relatively safe procedure with expanding indications, opportunities exist for the optimization of the current procedure. The investigators therefore propose, in a group of patients undergoing DBS surgery for the treatment of PD or ET, to use a combination of high‐field imaging modalities, intraoperative electrophysiology, external sensor interfaces, and computational modeling, to gather information on the utility of using these techniques to optimize DBS electrode placement and programming.

NCT ID: NCT01809613 Completed - Parkinson Disease Clinical Trials

Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease

Start date: March 2013
Phase: N/A
Study type: Observational

This study is investigating the usefulness of using functional magnetic resonance imaging (fMRI) to monitor brain activation during deep brain stimulation for Parkinson's Disease, Essential tremor, dystonia, OCD, depression, pain, Tourette's syndrome, and epilepsy. The study may determine the relationship between patterns of brain activation and therapeutic outcome and/or side effects.

NCT ID: NCT01764815 Completed - Parkinson's Disease Clinical Trials

Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation (DBS) Leads

Start date: December 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to provide proof-of-concept that directional stimulation, in an intraoperative setting, is perceivable in a subject and is different from omnidirectional stimulation. The tests will be performed using a dedicated DBS lead connected to external neurostimulator.

NCT ID: NCT01734122 Recruiting - Parkinson Disease Clinical Trials

Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

Start date: February 21, 2013
Phase:
Study type: Observational

The purpose of this study is to determine the changes in quality of life and degree of tremor for patients with essential tremor or Parkinsonian tremor who are treated by stereotactic radiosurgery (SRS). This is a questionnaire-based study. Please see Detailed Description below for more information.

NCT ID: NCT01705301 Completed - Parkinson's Disease Clinical Trials

Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation Neurosurgery

Start date: January 2010
Phase: N/A
Study type: Observational

In this study, the investigators will monitor extracellular neurotransmitter levels using a probe that is able to perform real time electrochemical detection during deep brain stimulation surgery. The overall question this study is designed to answer is: Are there neurotransmitters released during deep brain stimulation?

NCT ID: NCT01698450 Completed - Parkinson's Disease Clinical Trials

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders

Start date: November 2012
Phase: Phase 1
Study type: Interventional

The aim of this study is to asses the efficacy and the clinical safety of the transcranial magnetic resonance guided high intensity focused ultrasound system ExAblate 4000, InSightec Ltd. for functional neurosurgery in the treatment of movement disorders. The treatments to be conducted in this study are non-invasive, i.e. without opening the skull, and will create microthalamotomies in specific target areas such as thalamus, subthalamus and pallidum. The data obtained in this study will be used to evaluate the basic safety aspects of this new treatment technology and will serve as a basis for the clinical introduction of MR-guided ultrasound neurosurgery.